Table 1.
Patient demographics
| Total: | Men: N (%) | Women: N (%) | |
|---|---|---|---|
| 89 | 27 (30) | 62 (70) | |
| Total | Men | Women | |
| Age at symptom onset (yrs)1 | 42.15 (26.54; 51.15) | 40.36 (29.31; 51.38) | 42.66 (25.92; 51.15) |
| Age at diagnosis (yrs) | 44.06 (30.09; 52.38) | 44.83 (32.10; 54.17) | 43.58 (26.55; 51.82) |
| Age at index procedure (yrs) | 46.16 (37.98; 83.97) | 47.17 (37.62; 55.86) | 45.94 (37.40; 52.78) |
| Malignancy within 1 year of index procedure, N (%) | 4 (4.5) | ||
| History of pulmonary embolism, N (%) | 11 (12.4) | ||
| IVC filter placement | 12 (13.5) | ||
| Confirmed coagulopathies, total (N,%) | 27 (30) | ||
| Prothrombin G20210 | 1 (1) | ||
| Prothrombin G20210 and Factor V Leiden heterozygosity | 1 (1) | ||
| Factor V Leiden heterozygosity | 12 (13) | ||
| Factor V Leiden homozygosity | 2 (2) | ||
| Hyperhomocysteinemia | 1 (1) | ||
| Hyperhomocysteinemia with sickle cell trait | 1 (1) | ||
| Positive lupus anticoagulant / Antiphospholipid syndrome | 5 (6) | ||
| Protein C deficiency | 2 (2) | ||
| Protein S deficiency | 1 (1) | ||
| Unspecified thrombophilia | 1 (1) |
1
Median and interquartile range.